These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 16857194

  • 1. Circadian clock genes cause activation of the human PAI-1 gene promoter with 4G/5G allelic preference.
    Chong NW, Codd V, Chan D, Samani NJ.
    FEBS Lett; 2006 Aug 07; 580(18):4469-72. PubMed ID: 16857194
    [Abstract] [Full Text] [Related]

  • 2. Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.
    Ma Z, Jhun B, Jung SY, Oh CK.
    J Allergy Clin Immunol; 2008 Apr 07; 121(4):1006-1012.e2. PubMed ID: 18234320
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.
    Ma Z, Paek D, Oh CK.
    Clin Exp Allergy; 2009 Aug 07; 39(8):1136-44. PubMed ID: 19438580
    [Abstract] [Full Text] [Related]

  • 4. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
    Oishi K, Miyazaki K, Uchida D, Ohkura N, Wakabayashi M, Doi R, Matsuda J, Ishida N.
    J Mol Cell Cardiol; 2009 Apr 07; 46(4):545-52. PubMed ID: 19168071
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.
    Brogren H, Wallmark K, Jern S, Karlsson L.
    Thromb Res; 2008 Apr 07; 121(6):793-7. PubMed ID: 17884148
    [Abstract] [Full Text] [Related]

  • 8. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr 07; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 9. Distribution of PAI-1 promoter 4G/5G polymorphism in healthy Chinese and functional characterization using a luciferase reporter vector.
    Ding Z, Pan JQ.
    Ann Hematol; 2005 Mar 07; 84(3):183-7. PubMed ID: 15309528
    [Abstract] [Full Text] [Related]

  • 10. Involvement of circadian clock gene Clock in diabetes-induced circadian augmentation of plasminogen activator inhibitor-1 (PAI-1) expression in the mouse heart.
    Oishi K, Ohkura N, Amagai N, Ishida N.
    FEBS Lett; 2005 Jul 04; 579(17):3555-9. PubMed ID: 15950223
    [Abstract] [Full Text] [Related]

  • 11. Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1.
    Bergheanu SC, Pons D, Jukema JW, van der Hoeven BL, Liem SS, Vandenbroucke JP, Rosendaal FR, le Cessie S, Schalij MJ, van der Bom JG.
    Chronobiol Int; 2009 May 04; 26(4):637-52. PubMed ID: 19444746
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
    Ramón LA, Gilabert-Estellés J, Cosín R, Gilabert J, España F, Castelló R, Chirivella M, Romeu A, Estellés A.
    Thromb Res; 2008 Feb 01; 122(6):854-60. PubMed ID: 18423526
    [Abstract] [Full Text] [Related]

  • 15. Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients.
    Testa R, Bonfigli AR, Sirolla C, Boemi M, Manfrini S, Mari D, Testa I, Sacchi E, Franceschi C.
    Diabetes Nutr Metab; 2004 Aug 01; 17(4):217-21. PubMed ID: 15575342
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the ovine MT1 melatonin receptor promoter: interaction between multiple pituitary transcription factors at different phases of development.
    Johnston JD, Schuster C, Barrett P, Hazlerigg DG.
    Mol Cell Endocrinol; 2007 Mar 30; 268(1-2):59-66. PubMed ID: 17337323
    [Abstract] [Full Text] [Related]

  • 17. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
    Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF.
    Wien Klin Wochenschr; 2005 Oct 30; 117(19-20):707-10. PubMed ID: 16416371
    [Abstract] [Full Text] [Related]

  • 18. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.
    Hizawa N, Maeda Y, Konno S, Fukui Y, Takahashi D, Nishimura M.
    Clin Exp Allergy; 2006 Jul 30; 36(7):872-6. PubMed ID: 16839401
    [Abstract] [Full Text] [Related]

  • 19. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr 30; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
    Oishi K.
    Clin Exp Hypertens; 2009 May 30; 31(3):208-19. PubMed ID: 19387897
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.